Searches / Zhonghua Nei Ke Za Zhi [Chinese Journal Of Internal Medicine][JOURNAL]

Zhonghua Nei Ke Za Zhi [Chinese Journal Of Internal Medicine][JOURNAL]

Sun 200 papers
RSS

[The mechanism of thrombin in coagulation and therapeutic strategies for coagulation rebalancing].

Zhang P, Dai J, Tang YM … +1 more , Xu WQ

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218882 · Publisher ↗

Abstract loading — click title to view on PubMed.

[Central diabetes insipidus: diagnostic and therapeutic advances].

Zhang MY, Guo YF, Lyu ZH … +2 more , Mu YM, Guo QH

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218881 · Publisher ↗

Abstract loading — click title to view on PubMed.

[A case of calcium pyrophosphate deposition disease with crowned dens syndrome].

Li QH, Wang J, Yang ZH … +5 more , Hao SY, Ma JD, Yang LJ, Tao ZQ, Dai L

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218880 · Publisher ↗

Abstract loading — click title to view on PubMed.

[A case of intravascular large B-cell lymphoma with hemolytic anemia, neurological symptoms and negative PET/CT].

Liu S, Wei N, Guan A … +4 more , Jia CW, Chen M, Zhang Y, Wang W

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218879 · Publisher ↗

Abstract loading — click title to view on PubMed.

[A case report of delayed-onset diabetes mellitus complicated with primary adrenal insufficiency induced by immune checkpoint inhibitors].

Gao YL, Qiao TL, Jiang Y … +4 more , Guo D, Ju WX, Sun R, Sun H

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218878 · Publisher ↗

Abstract loading — click title to view on PubMed.

[Current status and factors influencing clinicians from different hospital levels and departments in remote patient management].

Zhao YZ, Wang ZX, Wang WY … +2 more , He L, Ma CS

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218877 · Publisher ↗

To analyze the current status and factors influencing clinician participation in remote patient management in China. In December 2023, a structured electronic questionnaire was administered to 7 980 clinicians, includin... To analyze the current status and factors influencing clinician participation in remote patient management in China. In December 2023, a structured electronic questionnaire was administered to 7 980 clinicians, including 930 cardiologists. The survey assessed clinicians' participation in online doctor-patient interactions; differences in hospital support across city tiers, hospital grades, professional titles, and departments; and factors influencing the willingness of clinicians to invest time in remote patient management. Among the 7 980 surveyed clinicians, online consultations had the highest participation rate (72.2%). Among cardiologists, participation rates for online consultations, health education, and post-consultation management were 73.3%, 66.9%, and 38.5%, respectively, which were relatively higher than those of other specialties. Hospital-based support for physicians in remote patient management showed significant variations across specialties and regions. Among cardiologists, 68.4% received "encouraging" policies, with the majority falling under "encouragement without incentive policies" (42.6%). In tier 3 cities, the proportion of physicians receiving "encouragement without incentive policies" was the highest (47.9%), while the proportion in the "cautious, requiring reporting" category was the lowest (3.9%). During remote patient management, the proportions of clinicians receiving support from professional teams were highest among those in tier 3 cities (29.6%) and cardiologists (30.5%). A significant interaction effect was observed between hospital policy and specialty (cardiologists vs. all clinicians) regarding physicians' willingness to invest time in remote patient management (=5.95, 0.001). Among cardiologists, those working in institutions with "encouraging, with incentives" policies reported a significantly longer median weekly investment time (10.0 h) compared to those under "neutral, unrestricted" policies (7.0 h, 0.001). Cardiologists with team support reported a significant increase in the time they were willing to invest (10 h/week) than those without team support (7.0 h/week, 0.001), although no significant interaction effect was found when compared with all clinicians (0.186). Cardiologists with a high online income (>5 000 Yuan/month) reported a significantly longer weekly investment time in remote management (25.0 h) compared to those with lower income (<200 yuan/month; 8.0 h, 0.001). However, whether the income met their personal expectations had no significant effect on their time commitment (0.638). Clinicians from tertiary hospitals and tier 3 cities demonstrated a higher level of engagement in remote patient management. Strengthening hospital policy support, enhancing team-based collaborations, and increasing online income levels may help promote the broader adoption of telemedicine.

[Analysis of current cardiac critical care development in Henan Province].

Cui Q, Wang WH, Yu D … +1 more , Zhang J

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218876 · Publisher ↗

To investigate the establishment, staffing, equipment allocation, and technological capabilities of cardiac intensive care units in public secondary and tertiary hospitals in Henan Province, and to provide a reference fo... To investigate the establishment, staffing, equipment allocation, and technological capabilities of cardiac intensive care units in public secondary and tertiary hospitals in Henan Province, and to provide a reference for promoting the development of nationwide cardiac critical care. In September 2023, supported by the Henan Provincial Health Commission, Cardiac Critical Care Committee of the Chinese Medical Doctor Association conducted the first comprehensive survey on the construction of cardiac intensive care units in Henan Province. A Chi-square test was used to compare the findings between secondary and tertiary hospitals. A total of 171 hospitals reported 1 602 cardiac intensive care unit beds, 1 091 physicians (physician-to-bed ratio: 0.68), and 2 298 nurses (nurse-to-bed ratio: 1.43). Tertiary hospitals had a significantly higher proportion of full-time physicians and physicians with a master's degree or above compared to secondary hospitals. Furthermore, tertiary hospitals had more nurses and a higher proportion of nurses with a bachelor's degree (all <0.05). Regarding equipment, tertiary hospitals demonstrated higher availability of activated clotting time (ACT) analyzers, temporary pacemakers, extracorporeal membrane oxygenation (ECMO) machines, intra-aortic balloon pumps (IABP), and pulse index continuous cardiac output (Picco) monitors (all 0.05). Among the hospitals surveyed, 123 could independently perform coronary interventional procedures, 93 could independently use an IABP, 26 could independently perform ECMO, and 53 offered continuous renal replacement therapy at the bedside. This study provides a preliminary understanding of the current state of cardiac critical care in Henan Province. Tertiary hospitals demonstrated advantages over secondary hospitals regarding medical staffing, the proportion of highly educated personnel, the availability of advanced equipment, such as ACT analyzers, temporary pacemakers, IABP, and Picco monitors, as well as in the performance of advanced procedures, including IABP and ECMO.

[Chinese expert consensus on MRI-guided thermal ablation for liver tumors (2025 edition)].

Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association, Ablation Expert Committee of the Chinese Society of Clinical Oncology, Tumor Ablation Subgroup of National Health Commission Comprehensive Interventional Therapy Quality Control Center … +2 more , Expert Group on Tumor Ablation Therapy of the Chinese Medical Doctors Association, Tumor Ablation Committee of the Chinese College of Interventionalists

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218875 · Publisher ↗

Image-guided thermal ablation (IGTA) has been widely used in the treatment of liver tumors. MRI-guided thermal ablation of liver tumors offers several advantages, including the absence of ionizing radiation; excellent so... Image-guided thermal ablation (IGTA) has been widely used in the treatment of liver tumors. MRI-guided thermal ablation of liver tumors offers several advantages, including the absence of ionizing radiation; excellent soft-tissue contrast; multi-parametric and multiplanar imaging; non-invasive, real-time temperature monitoring of the thermal field during the procedure; and accurate post-procedural assessment of therapeutic efficacy. To standardize and promote MRI-guided thermal ablation for liver tumors in China, advance the technological development of IGTA for tumor treatment, and enhance the efficacy of "precision ablation" for hepatic tumors, this expert consensus (2025 edition) was collaboratively developed by national experts from multiple societies and committees through multidisciplinary discussions. The contributing groups included the Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association, the Ablation Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Tumor Ablation Subgroup of the National Health Commission Comprehensive Interventional Therapy Quality Control Center, the Expert Group on Tumor Ablation Therapy of the Chinese Medical Doctors Association, and the Tumor Ablation Committee of the Chinese College of Interventionalists. The main contents of the consensus include: (1) indications, contraindications, and characteristics of MRI-guided thermal ablation for liver tumors; (2) MRI magnets, guidance sequences, and MRI-compatible thermal ablation equipment and instruments; and (3) protocols for MRI-guided thermal ablation of liver tumors, efficacy assessment, and the prevention and management of complications.

[Expert consensus on the multidisciplinary management of patients with heart failure and chronic obstructive pulmonary disease].

Electrophysiology and Cardiac Function Branch of Chinese Society of Geriatrics, Chronic Obstructive Pulmonary Disease Group, Chinese Thoracic Society

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218874 · Publisher ↗

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are common chronic conditions worldwide. The coexistence of HF and COPD creates a detrimental synergy that accelerates disease progression and substanti... Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are common chronic conditions worldwide. The coexistence of HF and COPD creates a detrimental synergy that accelerates disease progression and substantially worsens patient prognosis. To guide the evidence-based management of patients with HF and COPD, experts from the Cardiac Electrophysiology and Cardiac Function Branch of the Chinese Society of Geriatrics and the COPD Group of the Chinese Thoracic Society systematically reviewed the research progress, guidelines, and expert experience, formulating this consensus. The consensus covers epidemiological data, diagnosis, drug treatment, non-pharmacological interventions, and long-term management, while highlighting the critical role of multidisciplinary collaborations. Furthermore, it introduces an integrated diagnostic framework that addresses the complex interplay between HF and COPD. The document advocates for personalized therapeutic approaches and structured follow-up protocols to improve patient outcomes and quality of life.

[Expert consensus on endobronchial balloon occlusion in the treatment of hemoptysis (2025 edition)].

Clinical Guidelines Committee of Internal Medicine of Chinese Medical Association

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218873 · Publisher ↗

Hemoptysis is a serious medical emergency associated with high mortality rates. Notably, it poses significant therapeutic challenges owing to the complexities in rapidly identifying the bleeding site and underlying cause... Hemoptysis is a serious medical emergency associated with high mortality rates. Notably, it poses significant therapeutic challenges owing to the complexities in rapidly identifying the bleeding site and underlying cause. In severe cases, it can lead to death by asphyxia, thus necessitating prompt intervention. Bronchoscopy-guided endobronchial balloon occlusion (EBBO) is a vital procedure for blocking the bleeding bronchus, allowing time for subsequent embolization of the responsible vessel and definitive treatment. While traditional techniques for EBBO are intricate and demanding, recent advancements in balloon technology, along with procedural refinements, have simplified the process, reduced operation times, and enhanced medical staff proficiency. Nevertheless, a lack of standardized protocols and technical guidelines has hindered the widespread adoption of this technique in China. Accordingly, the Internal Medicine of Chinese Medical Association convened a group of experts to develop the "Expert consensus on endobronchial balloon occlusion in the treatment of hemoptysis (2025 edition)" to standardize this procedure. This consensus, grounded in evidence-based medicine and clinical practice both domestically and internationally, covers seven essential elements: treatment strategies, equipment, indications and contraindications, preoperative preparation, technical procedures and specifications, integration with other therapeutic techniques, efficacy assessment, and follow-up. By offering comprehensive guidance, the consensus aims to standardize and promote the use of EBBO for hemoptysis management in China.

[Chinese guidelines for the diagnosis and treatment of allergic asthma (the second edition, 2025)].

Chinese Society of Allergy, Chinese Society for the Promotion of Human Health Science and Technology Committee on Chronic Airway Disease

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218872 · Publisher ↗

Allergic asthma, a major phenotype of bronchial asthma, shares similarities and differences with non-allergic asthma in its pathogenesis, clinical manifestations, diagnostic approach and criteria, and intervention strate... Allergic asthma, a major phenotype of bronchial asthma, shares similarities and differences with non-allergic asthma in its pathogenesis, clinical manifestations, diagnostic approach and criteria, and intervention strategies. The "Chinese guidelines for the diagnosis and treatment of allergic asthma (2019, the first edition)" established a framework for standardizing clinical practice relating to this condition in China. Based on the first edition, this guideline combines recent research progress and novel clinical evidence to supplement and revise the epidemiology, pathogenesis, common allergens, clinical manifestations, diagnostic techniques and standards, treatment and prevention principles of allergic asthma. Key amendments were made to the definition and underlying mechanisms, allergen detection techniques, and endotype assessment. Based on the current landscape of allergic asthma management in China, the updated guidelines provide tailored diagnostic and therapeutic recommendations, especially for allergen-specific immunotherapy, biologic-targeted therapies, and tertiary prevention strategies. A total of 14 evidence-based recommendations are proposed, serving as a clinical reference (guiding document) for optimizing the diagnosis, treatment, and long-term management of allergic asthma in China.

[Allergic asthma: a common disease needing review].

Liu CT

Zhonghua Nei Ke Za Zhi · 2025 Nov · PMID 41218871 · Publisher ↗

Abstract loading — click title to view on PubMed.

[The 512th case: fever, cough, acute kidney injury].

Yu XC, Li HX, Chen MT … +6 more , Ma N, He K, Sun J, Niu JN, Wang Q, Xia P

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083399 · Publisher ↗

A 70-year-old female patient presented with fatigue and edema for 3 months and was found to have elevated serum creatinine for 3 weeks. During the course of the disease, she had fever and cough. Examinations revealed mul... A 70-year-old female patient presented with fatigue and edema for 3 months and was found to have elevated serum creatinine for 3 weeks. During the course of the disease, she had fever and cough. Examinations revealed multiple ground-glass opacities in both lungs and positivity for myeloperoxidase-anti-neutrophil cytoplasmic antibodies (ANCA), leading to a diagnosis of ANCA-associated vasculitis. The patient's condition initially improved after pulse glucocorticoid therapy combined with cyclophosphamide. During treatment, however, the patient developed hematochezia, and colonoscopy revealed multiple colonic ulcers. Immunohistochemistry of colonic mucosal biopsy confirmed cytomegalovirus (CMV) positivity, establishing a diagnosis of CMV colitis. The patient was found to have concurrent and pulmonary infections. During the disease course, the patient also developed deep vein thrombosis and roxadustat-associated central hypothyroidism. Given the presence of multiple comorbidities, rituximab was subsequently used for vasculitis treatment, resulting in sustained remission. This case highlights the importance of highly individualized treatment strategies for older patients with vasculitis, requiring adjustment of immunosuppressive therapy intensity based on disease progression.

[Advances on transcranial electromagnetic stimulation in improving non-motor symptoms of Parkinson's disease].

Gao YC, Zhuang S, Zhang Q … +10 more , Jiang QM, Wu JY, Cheng J, Zhang JR, Cheng XY, Zheng WB, Xu KW, Qiu TH, Mao CJ, Liu CF

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083398 · Publisher ↗

Abstract loading — click title to view on PubMed.

[Genetic and epigenetic mechanisms of insomnia].

Zhang TT, Wang YP

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083397 · Publisher ↗

Abstract loading — click title to view on PubMed.

[Advances in the mechanisms of kidney aging and intervention strategies: a research review].

Li MK, Zhang YB, He XW … +1 more , Ao QG

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083396 · Publisher ↗

Abstract loading — click title to view on PubMed.

[An adult case of pseudotumor-like overlapping syndrome of MOG antibody-related disease and NMDAR encephalitis].

Jiang HL, Ding Y, Wei H … +4 more , Li CJ, Gao YN, Guo LJ, Guo Y

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083395 · Publisher ↗

Abstract loading — click title to view on PubMed.

[A case of osteopetrosis type Ⅱ presenting with anemia, splenomegaly, and thrombocytopenia].

Chen MT, Shi XX, Cui LJ … +5 more , Ma MS, Zhang W, Cao XX, Zhou DB, Wei C

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083394 · Publisher ↗

Abstract loading — click title to view on PubMed.

[A case of xanthogranulomatous pyelonephritis associated with immunological abnormality and severe pulmonary infection].

Xing J, Chen D, Han YC … +3 more , Wang FM, Zhang XL, Liu BC

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083393 · Publisher ↗

Abstract loading — click title to view on PubMed.

[Clinical analysis of a motor neuron disease-like phenotype associated with anti-IgLON5 disease].

Guo Y, Li CJ, Wei H … +3 more , Ding Y, Guo LJ, Gao YN

Zhonghua Nei Ke Za Zhi · 2025 Oct · PMID 41083392 · Publisher ↗

We report a case of anti-IgLON5 disease with a motor neuron disease-like presentation admitted to the Department of Neurology, Xuanwu Hospital, Capital Medical University in July 2021. The patient was a 71-year-old femal... We report a case of anti-IgLON5 disease with a motor neuron disease-like presentation admitted to the Department of Neurology, Xuanwu Hospital, Capital Medical University in July 2021. The patient was a 71-year-old female who presented with the chief complaint of limb weakness persisting for 4 months. She showed progressive limb weakness accompanied by muscle atrophy. Electromyography (EMG) revealed extensive neurogenic damage. Initial serum evaluation for neural-specific autoantibodies was positive for IgLON5-Ab (1∶100). Repeat testing confirmed IgLON5-Ab positivity with a titer of 1∶1 000. The patient was diagnosed with anti-IgLON5 disease and treated with methylprednisolone and immunoglobulin, leading to clinical improvement. We found four relevant articles reporting a total of 11 similar cases. Thus, in this study, we analyzed a total of 12 cases, including our patient. Based on their clinical manifestations, these cases can be categorized into two types: amyotrophic lateral sclerosis(ALS)type and isolated bulbar type. Six cases-three males and three females-presented with the ALS type. Of these, three cases had diffuse limb weakness accompanied by muscle atrophy(two cases had diffuse hyperreflexia and one had a normal tendon reflex); one case presented with neck extensor weakness and bilateral asymmetric upper extremity weakness and was hyperreflexic at the bilateral patellar tendons; one case displayed asymmetric weakness in both lower limbs with normal deep reflexes, and one case exhibited neck weakness with hyperreflexia. EMG revealed diffuse lower motor neuron disease involving two or three regions. All patients tested positive for serum anti-IgLON5 antibodies. Four were also positive for anti-IgLON5 antibodies in cerebrospinal fluid, two were negative, and six were not tested. Among the 11 patients who received immunotherapy, 4 showed partial improvement in clinical symptoms, 2 exhibited transient improvement, 2 remained stable, and 3 showed no improvement. Testing for IgLON5-Ab should be considered among patients presenting with bulbar symptoms or ALS-like features, especially those with acute or subacute onset, rapid progression, autonomic dysfunction, vocal cord paralysis requiring tracheotomy, cognitive impairment, or involuntary movements. Early diagnosis and treatment may improve clinical symptoms and reduce adverse outcomes.
← Prev Page 5 of 10 Next →

About

Frequency
Sun
Papers found
200
RSS feed
Subscribe